Prevalence of Hearing Loss in Seniors Increases With Age
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, July 31, 2023 -- Older adults have a high prevalence of hearing loss, which increases with age, reaching 96.2 percent for those aged 90 years and older, according to a study published online July 28 in JAMA Network Open.
Nicholas S. Reed, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues estimated the prevalence of hearing loss and hearing aid use by age and demographic covariates in a sample of adults aged 71 years and older from the 2021 National Health Aging and Trends Study.
The researchers found that an estimated 65.3 percent of adults aged 71 years and older had at least some degree of hearing loss (mild, moderate, and severe for 37.0, 24.1, and 4.2 percent, respectively). White, male, lower-income, and lower education attainment subpopulations had a higher prevalence, and prevalence also increased with age, with hearing loss in 96.2 percent of adults aged 90 years or older. Only 29.2 percent of those with hearing loss used hearing aids, with Black and Hispanic and low-income individuals having lower estimates.
"These robust estimates from a nationally representative study that oversamples older adults are higher than previous estimates and provide updated metrics for resource planning related to ongoing and future hearing policy initiatives," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.